Immunological Protection against HPV16 E7-Expressing Human Esophageal Cancer Cell Challenge by a Novel HPV16-E6/E7 Fusion Protein Based-Vaccine in a Hu-PBL-SCID Mouse Model-Reference-Cited by-同舟云学术

Immunological Protection against HPV16 E7-Expressing Human Esophageal Cancer Cell Challenge by a Novel HPV16-E6/E7 Fusion Protein Based-Vaccine in a Hu-PBL-SCID Mouse Model

Published:2007 Issue:1 Volume:30 Page:150-156
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Lu Yuanzhi¹,Zhang Zhixin²,Liu Qiao¹,Liu Bo¹,Song Xinxin¹,Wang Mingrong³,Zhao Xinhua¹,Zhao Qingzheng¹

Affiliation:

1. Laboratory of Cellular and Molecular Biology, Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

2. Beijing Blood Center

3. State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/30/1/30_1_150/_pdf

Reference50 articles.

1. 1) Parkin D. M., Bray F., Ferlay J., Pisani P., CA Cancer J. Clin., 55, 74—108 (2005).

2. 2) Tew W. P., Kelsen D. P., Ilson D. H., Oncologist, 10, 590—601 (2005).

3. 3) McCabe M. L., Dlamini Z., Int. Immunopharmacol., 5, 111—330 (2005).

4. 4) Cervantes J., Rev. Gastroenterol. Peru., 24, 165—170 (2004).

5. 5) Syrjanen K. J., J. Clin. Pathol., 55, 721—728 (2002).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and immune effect of an HPV16/18/58 trivalent therapeutic adenovirus vector vaccine;Infectious Agents and Cancer;2022-02-23

2. Association of CTLA‐4 , TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma;Scandinavian Journal of Immunology;2019-10-03

3. REBACIN® as a noninvasive clinical intervention for high‐risk human papillomavirus persistent infection;International Journal of Cancer;2019-04-29

4. Identification and characterization of enhancer agonist human cytotoxic T-cell epitopes of the human papillomavirus type 16 (HPV16) E6/E7;Vaccine;2017-05

5. Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma;International Immunopharmacology;2015-10